Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects. Mailhot-Larouche S, Busby J, Couillard S. Eur Respir J 2025;65:2402057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mailhot-Larouche S, Busby J, Couillard S. Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects. Eur Respir J 2025;65:2402057.
PMID: 39947688